Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xin Pu Yin (新蒲饮) is a traditional Chinese medicine (TCM) herbal formula. The name translates to "New Phragmites Drink" or "New Reed Decoction." It is not a single pharmaceutical compound but rather a classical multi-herb decoction used in TCM practice. Such formulas are typically composed of several plant-based ingredients, each selected for their synergistic effects according to TCM theory. The specific composition and indications of Xin Pu Yin are not detailed in the provided sources, and it does not appear in major English-language pharmacopoeias or clinical trial registries as a standardized modern drug. In general, similar TCM formulas may be used for conditions such as febrile diseases, detoxification, or clearing heat and dampness from the body; however, without explicit documentation for this particular formula, its exact mechanism of action and primary indications remain unclear.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on xin pu yin.